Patent · US Active

GH9 endoglucanase variants and polynucleotides encoding same

US11525128B2 · kind B2 · utility

0Cited by

2References

22Claims

0Family size

Assignee

Novozymes A/S · DK

Inventors

Rune Nygaard Monrad · Hillerød, DK
Vasudeva Prahlada Rao · Savanuru, IN
Rajendra Kulothungan Sainathan · Bengaluru, IN
Sohel Dalal · Ahmedabad, IN
VSanthosh Vasu Mepadam · Kanchinakote, IN
Allan Svendsen · Paseo Los Muchachos, DK
Mette Louise Dissing Overgaard · Copenhagen, DK
Lars Andersen
Geetha Hiremath Mendez · Bengaluru, IN

Key dates

Filing date	Aug 3, 2018
Grant date	Dec 13, 2022
Priority date	—
Expiry date	Aug 3, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y302/01004
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to endoglucanase variants and methods for obtaining endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.